The Journal of Practical Medicine ›› 2026, Vol. 42 ›› Issue (1): 87-93.doi: 10.3969/j.issn.1006-5725.2026.01.011
• Chronic Disease Control • Previous Articles Next Articles
Jia LI,Xinyue LIU,Jia SHI,Xiaoxuan FAN,Su LIU(
)
Received:2025-09-27
Online:2026-01-10
Published:2026-01-14
Contact:
Su LIU
E-mail:nfmkls@163.com
CLC Number:
Jia LI,Xinyue LIU,Jia SHI,Xiaoxuan FAN,Su LIU. Analysis of risk factors associated with kidney injury in early-onset type 2 diabetes mellitus[J]. The Journal of Practical Medicine, 2026, 42(1): 87-93.
Tab.1
Baseline characteristics comparison between EOT2DM patients with and without renal impairment"
| 项目 | 伴肾损组 (n = 241) | 不伴有肾损组(n = 300) | t/χ2/Z值 | P值 |
|---|---|---|---|---|
| 年龄/年 | 42.73 ± 0.86 | 38.83 ± 0.61 | -3.11 | 0.002 |
| 性别/[例(%)] | 2.45 | 0.117 | ||
| 男 | 171(71.0) | 192(64.2) | ||
| 女 | 70(29.0) | 107(35.8) | ||
| DM病程/年 | 8.42 ± 0.55 | 8.78 ± 0.56 | -0.45 | 0.655 |
| DM家族史/[例(%)] | 97(40.2) | 135(45.2) | 1.12 | 0.291 |
| 高血压病史 | 92(38.2) | 56(18.7) | 24.39 | < 0.01 |
| t-PAIC/(ng/mL) | 6.62 ± 0.30 | 6.79 ± 0.29 | 0.35 | 0.726 |
| PIC/(μg/mL) | 0.55 ± 0.02 | 0.46 ± 0.01 | -2.90 | 0.004 |
| sTM/(TU/mL) | 9.58 ± 0.33 | 7.13 ± 0.11 | -7.00 | < 0.01 |
| TAT/(ng/mL) | 1.63 ± 0.10 | 1.75 ± 0.15 | 0.34 | 0.735 |
| ALT/(U/L) | 42.51 ± 3.09 | 43.93 ± 3.15 | 0.77 | 0.443 |
| UA/(umol/L) | 372.84 ± 6.91 | 328.91 ± 5.47 | -4.90 | < 0.01 |
| TG/(mmol/L) | 3.52 ± 0.27 | 2.62 ± 0.18 | -4.00 | < 0.01 |
| LDL-C/(mmol/L) | 2.78 ± 0.06 | 2.83 ± 0.05 | 0.99 | 0.320 |
| FBG/(mmol/L) | 8.30 ± 0.23 | 8.06 ± 0.18 | -0.29 | 0.773 |
| HbA1C/% | 9.16 ± 0.14 | 8.96 ± 0.13 | -1.15 | 0.249 |
| CP/(ng/mL) | 2.23 ± 0.10 | 1.98 ± 0.09 | -1.78 | 0.076 |
| TSH/(μIU/mL) | 2.25 ± 0.10 | 2.25 ± 0.18 | -0.82 | 0.410 |
| FT4/(ng/dL) | 1.09 ± 0.10 | 0.99 ± 0.04 | -0.75 | 0.455 |
| 颈动脉斑块 | 14.69 | < 0.01 | ||
| 无 | 82(36.3) | 141(51.8) | ||
| 内膜增厚 | 22(9.7) | 30(11.0) | ||
| 有 | 122(54.0) | 101(37.1) | ||
| BMI/(kg/m2) | 28.21 ± 0.33 | 27.46 ± 0.26 | -1.38 | 0.166 |
| PBF | 32.93 ± 0.52 | 32.42 ± 0.43 | -0.90 | 0.369 |
| WHR | 0.95 ± 0.00 | 0.94 ± 0.00 | -2.48 | 0.013 |
| VFA | 129.04 ± 3.33 | 118.95 ± 2.75 | -2.26 | 0.024 |
| SMI | 7.81 ± 0.07 | 7.61 ± 0.06 | -2.08 | 0.037 |
Tab.2
Multivariate logistic regression analysis of risk factors for renal impairment in EOT2DM"
| 项目 | OR | 95%CI | P值 |
|---|---|---|---|
| 年龄 | 1.004 | 0.975 ~ 1.035 | 0.774 |
| 性别 | 1.579 | 0.918 ~ 2.716 | 0.099 |
| 高血压病史 | 1.294 | 0.752 ~ 2.229 | 0.352 |
| PIC | 2.209 | 0.549 ~ 8.887 | 0.264 |
| sTM | 1.371 | 1.212 ~ 1.550 | 0.000 |
| ALT | 0.997 | 0.991 ~ 1.003 | 0.338 |
| UA | 1.003 | 1.000 ~ 1.006 | 0.021 |
| TG | 1.125 | 1.044 ~ 1.212 | 0.002 |
| LDL-C | 0.736 | 0.552 ~ 0.983 | 0.038 |
| 颈动脉斑块 | 2.443 | 1.324 ~ 4.508 | 0.004 |
| WHR | 1.113 | 0.511 ~ 3.226 | 0.003 |
| [1] |
GENITSARIDI I S P, SALIM A S S F, TOMIC D J S, et al. Idf Diabetes Atlas: Global, Regional and National Diabetes Prevalence Estimates for 2024 and Projections for 2050[J]. SSRN, 2025:1-2.doi: 10.1016/j.diabres.2021.109119 .
doi: 10.1016/j.diabres.2021.109119 |
| [2] |
International Diabetes Federation. IDF Global Clinical Practice Recommendations for Managing Type 2 Diabetes 2025[J]. Diabetes Res Clin Pract, 2025, 224: 112238. doi: 10.1016/j.diabres.2025.112238 .
doi: 10.1016/j.diabres.2025.112238 |
| [3] |
袁慧娟, 杨俊朋, 邓欣如, 等. 成人早发2型糖尿病诊治专家共识[J]. 中华实用诊断与治疗杂志, 2022, 36(12): 1189-1198. doi:10.13507/j.issn.1674-3474.2022.12.001 .
doi: 10.13507/j.issn.1674-3474.2022.12.001 |
| [4] |
ZHAO M, SONG L, SUN L, et al. Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study[J]. Diabetes Care, 2021, 44(6): 1426-1432.doi: 10.2337/dc20-2375 .
doi: 10.2337/dc20-2375 |
| [5] |
MISRA S, KE C, SRINIVASAN S, et al. Current insights and emerging trends in early-onset type 2 diabetes[J]. Lancet Diabetes Endocrinol, 2023, 11(10): 768-782. doi: 10.1016/S2213-8587(23)00225-5 .
doi: 10.1016/S2213-8587(23)00225-5 |
| [6] |
WU Y, WANG Y, ZHANG J, et al. Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: A biopsy-based study[J]. Aging (Albany NY), 2021, 13(6): 8146-8154. doi: 10.18632/aging.202624 .
doi: 10.18632/aging.202624 |
| [7] |
LIU J J, LIU S, GURUNG R L, et al. Risk of progressive chronic kidney disease in individuals with early-onset type 2 diabetes: A prospective cohort study[J]. Nephrol Dial Transplant, 2020, 35(1): 115-121.doi: 10.1093/ndt/gfy211 .
doi: 10.1093/ndt/gfy211 |
| [8] |
KE C, SHAH B R, LUK A O, et al. Cardiovascular outcomes trials in type 2 diabetes: Time to include young adults[J]. Diabetes Obes Metab, 2020, 22(1): 3-5. doi: 10.1111/dom.13874 .
doi: 10.1111/dom.13874 |
| [9] |
SARGEANT J A, BRADY E M, ZACCARDI F, et al. Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trials[J]. Diabetologia, 2020, 63(8): 1516-1520. doi: 10.1007/s00125-020-05174-9 .
doi: 10.1007/s00125-020-05174-9 |
| [10] |
LASCAR N, BROWN J, PATTISON H, et al. Type 2 diabetes in adolescents and young adults[J]. Lancet Diabetes Endocrinol, 2018, 6(1): 69-80. doi: 10.1016/S2213-8587(17)30186-9 .
doi: 10.1016/S2213-8587(17)30186-9 |
| [11] |
NORMAN G, MONTEIRO S, SALAMA S. Sample size calculations: should the emperor's clothes be off the peg or made to measure[J]. BMJ,2012,345: e5278. doi: 10.1136/bmj.e5278 .
doi: 10.1136/bmj.e5278 |
| [12] |
JUFAR A H, LANKADEVA Y R, MAY C N, et al. Renal functional reserve: From physiological phenomenon to clinical biomarker and beyond[J]. Am J Physiol Regul Integr Comp Physiol, 2020, 319(6): R690-R702.doi: 10.1152/ajpregu.00237.2020 .
doi: 10.1152/ajpregu.00237.2020 |
| [13] |
SÁNCHEZ-HIDALGO J J, SUÁREZ-CUENCA J A, LOZANO-NUEVO J J, et al. Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: A case control study[J]. Diabetol Metab Syndr, 2021, 13(1): 128.doi: 10.1186/s13098-021-00745-1 .
doi: 10.1186/s13098-021-00745-1 |
| [14] |
郝宝顺, 张辉, 刘雪莲, 等. 糖尿病早期肾病患者血管内皮功能的超声研究[J]. 中华临床医师杂志(电子版), 2011, 5(18): 5331-5335. doi: 10.3877/cma.j.issn.1674-0785. 2011. 18.021 .
doi: 10.3877/cma.j.issn.1674-0785. 2011. 18.021 |
| [15] |
MAGLIANO D J, SACRE J W, HARDING J L, et al. Young-onset type 2 diabetes mellitus-implications for morbidity and mortality[J]. Nat Rev Endocrinol, 2020, 16(6): 321-331. doi: 10.1038/s41574-020-0334-z .
doi: 10.1038/s41574-020-0334-z |
| [16] |
刘晓, 白海龙, 边云. 糖尿病肾病患者血栓相关因子动态评估对血栓风险的预测价值[J]. 中国临床研究, 2024, 37(7): 1055-1059.doi: 10.13429/j.cnki.cjcr.2024.07.014 .
doi: 10.13429/j.cnki.cjcr.2024.07.014 |
| [17] |
LASZIK Z G, ZHOU X J, FERRELL G L, et al. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis[J]. Am J Pathol, 2001, 159(3): 797-802. doi: 10.1016/S0002-9440(10)61753-1 .
doi: 10.1016/S0002-9440(10)61753-1 |
| [18] |
DROŻDŻ D, ŁĄTKA M, DROŻDŻ T, et al. Thrombomodulin as a New Marker of Endothelial Dysfunction in Chronic Kidney Disease in Children[J]. Oxid Med Cell Longev, 2018, 2018: 1619293. doi: 10.1155/2018/1619293 .
doi: 10.1155/2018/1619293 |
| [19] |
张心钰, 田风胜. 纤维蛋白原与糖尿病肾病相关性的研究进展[J]. 中国医药导报, 2023, 20(18): 61-64.doi: 10.20047/j.issn1673-7210.2023.18.13 .
doi: 10.20047/j.issn1673-7210.2023.18.13 |
| [20] |
ISERMANN B, VINNIKOV IA, MADHUSUDHAN T, et al. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis[J]. Nat Med, 2007,13(11): 1349-58.doi: 10.1038/nm1667 .
doi: 10.1038/nm1667 |
| [21] |
YANG S M, KA S M, WU H L, et al. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis[J]. Diabetologia, 2014,57(2): 424-434.doi: 10.1007/s00125-013-3115-6 .
doi: 10.1007/s00125-013-3115-6 |
| [22] |
BALDRIGHI M, MALLAT Z, LI X. NLRP3 inflammasome pathways in atherosclerosis[J]. Atherosclerosis, 2017, 267: 127-138. doi: 10.1016/j.atherosclerosis.2017.10.027 .
doi: 10.1016/j.atherosclerosis.2017.10.027 |
| [23] |
IWASHIMA Y, SATO T, WATANABE K, et al. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy[J]. Diabetes, 1990, 39(8): 983-988. doi: 10.2337/diab.39.8.983 .
doi: 10.2337/diab.39.8.983 |
| [24] |
LI W, SHENG S, ZHU F. Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis[J]. Thromb Res, 2025, 249: 109302. doi: 10.1016/j.thromres.2025.109302 .
doi: 10.1016/j.thromres.2025.109302 |
| [25] |
HUANG Y, FU R, ZHANG J, et al. Dynamic changes in metabolic syndrome components and chronic kidney disease risk: A population-based prospective cohort study[J]. BMC Endocr Disord, 2025, 25(1): 137. doi: 10.1186/s12902-025-01958-5 .
doi: 10.1186/s12902-025-01958-5 |
| [26] |
GUAN M, CUI S, SONG H, et al. Association between the triglyceride to high-density lipoprotein cholesterol ratio and diabetes mellitus likelihood in patients with chronic kidney disease[J]. BMC Nephrol, 2025, 26(1): 470. doi: 10.1186/s12882-025-04377-9 .
doi: 10.1186/s12882-025-04377-9 |
| [27] |
KEANE W F, TOMASSINI J E, NEFF D R. Lipid abnormalities in patients with chronic kidney disease: Implications for the pathophysiology of atherosclerosis[J]. J Atheroscler Thromb, 2013, 20(2): 123-33. doi: 10.5551/jat.12849 .
doi: 10.5551/jat.12849 |
| [28] |
GONG L, WANG C, NING G, et al. High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study[J]. Diabetes Obes Metab, 2021, 23(11): 2551-2560. doi: 10.1111/dom. 14502 .
doi: 10.1111/dom. 14502 |
| [29] |
PONTREMOLI R, DESIDERI G, ARCA M, et al. Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study[J]. Eur J Intern Med, 2023, 111: 90-96. doi: 10.1016/j.ejim.2023.02.019 .
doi: 10.1016/j.ejim.2023.02.019 |
| [30] |
REN L, CUI H, WANG Y, et al. The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects[J]. Biomed Pharmacother, 2023, 161: 114465. doi: 10.1016/j.biopha.2023.114465 .
doi: 10.1016/j.biopha.2023.114465 |
| [31] |
YU H, XIE L F, CHEN K, et al. Initiating Characteristics of Early-onset Type 2 Diabetes Mellitus in Chinese Patients[J]. Chin Med J (Engl), 2016,129(7): 778-784. doi: 10.4103/0366-6999.178959 .
doi: 10.4103/0366-6999.178959 |
| [32] |
REZAEE A, DARROUDI S, YAVARI A, et al. Novel anthropometric and lipid indices as predictors of chronic kidney disease: Insights from a decade-long cohort study[J]. J Health Popul Nutr, 2025, 44(1): 227. doi: 10.1186/s41043-025-00924-0 .
doi: 10.1186/s41043-025-00924-0 |
| [33] |
DI SESSA A, PASSARO A P, COLASANTE A M, et al. Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype[J]. Int J Obes (Lond), 2023, 47(12): 1247-1255. doi: 10.1038/s41366-023-01379-1 .
doi: 10.1038/s41366-023-01379-1 |
| [34] |
BJERGFELT S S, SØRENSEN I, HJORTKJÆR H Ø, et al. Carotid plaque thickness is increased in chronic kidney disease and associated with carotid and coronary calcification[J]. PLoS One, 2021, 16(11): e0260417. doi: 10.1371/journal.pone.0260417 .
doi: 10.1371/journal.pone.0260417 |
| [35] |
WATRAL J, FORMANOWICZ D, PEREK B, et al. Comprehensive proteomics of monocytes indicates oxidative imbalance functionally related to inflammatory response in chronic kidney disease-related atherosclerosis[J]. Front Mol Biosci, 2024, 11: 1229648. doi: 10.3389/fmolb.2024.1229648 .
doi: 10.3389/fmolb.2024.1229648 |
| [36] |
WANG L, WANG J, JI J, et al. Associations between inflammatory markers and carotid plaques in CKD: Mediating effects of eGFR-a cross-sectional study[J]. BMC Nephrol, 2024, 25(1): 374. doi: 10.1186/s12882-024-03826-1 .
doi: 10.1186/s12882-024-03826-1 |
| [37] |
HIRANO T, SATOH N, KODERA R, et al. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort[J]. J Diabetes Investig, 2022, 13(4): 657-667. doi: 10.1111/jdi. 13697 .
doi: 10.1111/jdi. 13697 |
| [38] |
HIRANO T. Pathophysiology of Diabetic Dyslipidemia[J]. J Atheroscler Thromb, 2018, 25(9): 771-782. doi: 10.5551/jat.RV17023 .
doi: 10.5551/jat.RV17023 |
| [39] |
叶健华, 赵玉钏. 2型糖尿病缓解标准与治疗策略[J]. 实用医学杂志,2023,39(14):1729-17320. doi: 10.3969/j.issn.1006-5725.2023.14.001 .
doi: 10.3969/j.issn.1006-5725.2023.14.001 |
| [1] | Zhouzhan LUO,Qingling HU,Qiaofeng WANG,Guolong LEI,Mengyao TANG,Chao PENG,Yingying TANG. Value of left ventricular contrast echocardiography and three-dimensional echocardiography heart model parameters on predicting major adverse cardiovascular events in patients with coronary heart disease after percutaneous coronary intervention [J]. The Journal of Practical Medicine, 2026, 42(1): 110-118. |
| [2] | Yunting ZHUANG,Yao SONG,Qian CHEN,Yanxuan XIAO,Tian TAN,Wenhui LI,Ruiyan BAI,Zeshan LIN,Zhijian. WANG. Risk factor analysis and predictive indicators of postpartum haemorrhage in singleton pregnant women with severe preeclampsia [J]. The Journal of Practical Medicine, 2025, 41(8): 1155-1160. |
| [3] | Runfang WANG,Ya DUAN,Liyan DU,Xiaodan LIU,Wenning LIAN,Yan HUO,Dandan. YANG. Epidemiological status and risk factors associated with placental abruption among pregnant women in Hebei Province [J]. The Journal of Practical Medicine, 2025, 41(6): 904-910. |
| [4] | Dongli LIU,Zilin QUAN,Lingxiu ZHONG,Qiqi CHEN,Wenqiao CAI,Senpei ZHUANG,Ying WEI,Huiyi PAN,Yawen. LIN. Construction and validation of a predictive model for antibiotic-associated diarrhea after surgery in children with congenital heart disease [J]. The Journal of Practical Medicine, 2025, 41(5): 683-690. |
| [5] | Qiaoying MO,Fangyi ZHU,Cunkui ZHU,Shenglong. MA. Nomogram model of malnutrition risk in patients suffering from chronic heart failure grounded on GNRI score [J]. The Journal of Practical Medicine, 2025, 41(5): 691-698. |
| [6] | Kaiyang WANG,Jiahui YONG,Jing TAO,Xin. SHEN. Correlation between atherogenic index of plasma and prognosis of patients with acute myocardial infarction [J]. The Journal of Practical Medicine, 2025, 41(23): 3697-3703. |
| [7] | Weihao LIANG,Chen LIU,Yugang. DONG. China cardiovascular health and disease report 2024: Managing cardiovascular risk factors remains a challenging task [J]. The Journal of Practical Medicine, 2025, 41(21): 3311-3314. |
| [8] | Xiudong YANG,Xing LIU,Xin LIU,Yan JIANG,Wei WANG,Zongbin HE,Sha HUANG,Meihong WEN,Yazhen. LIU. Construction and clinical validation of a machine learning⁃based nomogram model for predicting lymphatic leakage following radical prostatectomy [J]. The Journal of Practical Medicine, 2025, 41(21): 3378-3384. |
| [9] | Xiaoying DING,Zhichao DONG,Jianna MAO,Changqing GUO,Aimin. YUE. Expression and clinical significance of serum CXCL1 and PRDM5 in lymph node metastasis of progressive gastric cancer [J]. The Journal of Practical Medicine, 2025, 41(20): 3206-3213. |
| [10] | Xiaozhen JIANG,Xiuxian CHEN,Wenming LI. Analysis of risk factors for pegaspargase⁃associated acute pancreatitis in childhood with B⁃cell acute lymphoblastic leukemia [J]. The Journal of Practical Medicine, 2025, 41(18): 2853-2858. |
| [11] | Dehong LI,Maomei NI,Ting CAI,Juanjuan REN. Risk factors for postoperative recurrence in patients with chronic sinusitis and nasal polyps treated by endoscopic sinus surgery [J]. The Journal of Practical Medicine, 2025, 41(18): 2928-2936. |
| [12] | Mingbo LIU,Xinye HE,Xiaohong YANG,Zengwu. WANG. Interpretation of annual report on cardiovascular health and diseases in China 2024 [J]. The Journal of Practical Medicine, 2025, 41(14): 2111-2131. |
| [13] | Zhiqing XIAO,Xue WU,Rui QIU,Jinghan CHI,Shaodong HUA,Bin ZHU,De CHANG. Construction and verification of multi⁃factor prediction model for refractory mycoplasma pneumoniae pneumonia in children [J]. The Journal of Practical Medicine, 2025, 41(13): 2004-2010. |
| [14] | Shulian GAO,Lingxiu ZHONG,Yamin SONG,Lixia LIN,Senpei ZHUANG,Jian TAO. Risk factors of tracheal reintubation after total aortic arch replacement [J]. The Journal of Practical Medicine, 2025, 41(11): 1681-1686. |
| [15] | Peng YANG,Yimeng XU,Wei HAN. Risk factors for postoperative pulmonary infection after pancreaticoduodenectomy and establishment of predictive model [J]. The Journal of Practical Medicine, 2025, 41(11): 1705-1710. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||

